Regulation of 5′-AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 4 47-4, 2003, Pages

  Wojtaszewski, Jorgen F P ^a,d   MacDonald, Christopher ^a   Nielsen, Jakob N ^a   Hellsten, Ylva ^a   Grahame Hardie, D ^b   Kemp, Bruce E ^c   Kiens, Bente ^a   Richter, Erik A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acetyl CoA carboxylase; Catecholamines; Fatty acids; Glycogen

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; CATECHOLAMINE; GLUCOSE; GLYCOGEN; ISOENZYME; LONG CHAIN FATTY ACID; PROTEIN KINASE; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; FATTY ACID; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE;

ADULT; ARTICLE; ATHLETE; CONTROLLED STUDY; CYCLING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE EXERCISE; MUSCLE METABOLISM; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SKELETAL MUSCLE; BLOOD; BLOOD FLOW; CLINICAL TRIAL; ENZYME SPECIFICITY; EXERCISE; GLUCOSE BLOOD LEVEL; LEG; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; VASCULARIZATION;

ACETYL-COA CARBOXYLASE; ADULT; BLOOD GLUCOSE; CATECHOLAMINES; EXERCISE; FATTY ACIDS; GLYCOGEN; HUMANS; LEG; MALE; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; REGIONAL BLOOD FLOW; SUBSTRATE SPECIFICITY;

EID: 0037375970     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00436.2002     Document Type: Article

References (61)

1. Alam N and Saggerson ED. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem J 334: 233-241, 1998.
2. Andersen PH and Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 366: 233-249, 1985.
3. Båvenholm PN, Pigon J, Saha AK, Ruderman NB, and Efendic S. Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes 49: 1078-1083, 2000.
4. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377-381, 1982.
5. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
6. Cheung CF, Salt IP, Davies A, Hardie DG, and Carling D. Characterization of AMP-activated protein kinase gamma subunit isoforms and their role in AMP binding. Biochem J 346: 659-669, 2000.
7. Chien D, Dean D, Saha AK, Flatt JP, and Ruderman NB. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinol Metab 279: E259-E265, 2000.
8. Davies SP, Sim AT, and Hardie DG. Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem 187: 183-190, 2001.
9. Dean DJ, Daugaard JR, Young ME, Saha A, Vavvas D, Asp S, Kiens B, Kim KH, Witters LA, Richter EA, and Ruderman NB. Exercise disminishes the activity of acetyl CoA carboxylase in human muscle. Diabetes 49: 1295-1300, 2000.
10. Derave W, Ihlemann J, Witters L, Kristiansen S, Richter EA, and Ploug T. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 49: 1281-1287, 2000.
11. Derave W, Lund S, Holman GD, Wojtaszewski JFP, Pedersen O, and Richter EA. Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content. Am J Physiol Endocrinol Metab 277: E1103-E1110, 1999.
12. Frayn K. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
13. Fryer LG, Parbu-Patel A, and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. JBiol Chem 277:25226-25232, 2002.
14. Fujii N, Hayashi T, Hirshman MF, Smith TJ, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, and Goodyear LJ. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150-1155, 2000
15. Gollnick PD, Pernow B, Essen B, Jansson E, and Saltin B. Availability of glycogen and plasma FFA for substrate utilization in leg muscle of man during exercise. Clin Physiol 1: 27-42, 1981.
16. Goodyear LJ. AMP activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport. Exerc Sports Sci Rev 28: 113-116, 2000.
17. Ha J, Daniel S, Broyles SS, and Kim KH. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol Chem 269:22162-22168, 1994.
18. Habinowski SA, Hirshman MF, Fakamoto K, Kemp BE, Gould SL, Goodyear LJ, and Witters LA. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch Biochem Biophys 396: 71-79, 2001.
19. Hardie DG, Carling D, and Carlson M. The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
20. Hawley SA, Gadalla AE, Olsen GS, and Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420-2425, 2002.
21. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ. Metabolic stress and altered glucose transport. Diabetes 49: 527-531, 2000.
22. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
23. Hespel P and Richter EA. Glucose uptake and transport in contracting, perfused rat muscle with different pre-contraction glycogen concentrations. J Physiol 427: 347-359, 1990.
24. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, and Ruderman NB. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281: E335-E340, 2001.
25. Kawanaka K, Nolte LA, Han DH, Hansen PA, and Holloszy JO. Mechanisms underlying impaired GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats. Am J Physiol Endocrinol Metab 279: E1311-E1318, 2000.
26. Lowry OH and Passonneau JV. A Flexible System of Enzymatic Analysis. London: Academic, 1972.
27. Markuns JF, Wojtaszewski JFP, and Goodyear LJ. Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle. J Biol Chem 274: 24896-24900, 1999.
28. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. Fatty acid oxidation and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
29. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
30. Moule SK and Denton RM. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett 439: 287-290, 1998.
31. Mu J, Brozinick JT Jr, Valladares O, Bucan M, and Birnbaum M. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
32. Musi N, Fujii N, Hirshman MF, Ekberg I, Fröberg S, Ljungqvist O, Thorell A, and Goodyear LJ. AMP activated protein kinase is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50: 921-927, 2001.
33. Musi N, Hayashi Y, Fujii N, Hirshman MF, Witters LA, and Goodyear LJ. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280: E677-E684, 2001.
34. Nielsen JN, Mustard K, Graham D, Pilegaard H, Haiyan Y, Goodyear LJ, Hardie DG, Richter EA, and Wojtaszewski JFP. AMPK actvity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631-641, 2003.
35. Nielsen JN, Wojtaszewski JFP, Haller RG, Hardie DG, Kemp BE, Richter EA, and Vissing J. Role of 5′AMP-activated protein kinase in glycogen synthase activity and glucose utilization in skeletal muscle; insights from patients with McArdle's disease. J Physiol 541: 979-989, 2002.
36. Odland LM, Heigenhauser GJ, Lopaschuk GD, and Spriet LL. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am J Physiol Endocrinol Metab 270: E541-E544, 1996.
37. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E, and Spriet LL. Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am J Physiol Endocrinol Metab 274: E1080-E1085, 1998.
38. Olsen GS and Hansen BF. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle. Am J Physiol Endocrinol Metab 283: E965-E970, 2002.
39. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB, and Saha AK. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277:32571-32577, 2002.
40. Patel N, Khayat ZA, Ruderman NB, and Klip A. Dissociation of 5′AMP activated protein kinase activation and glucose uptake stimulation by mitochondrial uncoupling and hyperosmolar stress: differential sensitivities to intracellular calcium and protein kinase C inhibition. Biochem Biophys Res Commun 285: 1066-1070, 2001.
41. Richter EA and Galbo H. High glycogen levels enhance glycogen breakdown in isolated contracting skeletal muscle. J Appl Physiol 61: 827-831, 1986.
42. Richter EA, Mikines KJ, Galbo H, and Kiens B. Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 66: 876-885, 1989.
43. Saha AK, Kurowski TG, and Ruderman NB. A malonyl-CoA fuel sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am J Physiol Endocrinol Metab 269: E283-E289, 1995.
44. Saha AK, Schwarsin AJ, Roduit R, Masse F, Kaushik V, Tornheim K, Prentki M, and Ruderman NB. Activation of malonyl CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-l-beta-D-ribofuranoside. J Biol Chem 24279-24283, 2000.
45. Sakoda H, Ogihara T, Anai M, Fujishiro M, Ono H, Onishi Y, Katagiri H, Abe M, Fukushima Y, Shojima N, Inukai K, Kikuchi M, Oka Y, and Asano T. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 282: E1239-E1244, 2OO2.
46. Salt IP, Johnson G, Ashcroft SJ, and Hardie DG. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J 335: 533-539, 1998.
47. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, and Wolfe RR. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 98: 2244-2250, 1996.
48. Shimizu S, Inoue K, Tani Y, and Yamada H. Enzymatic microdetermination of serum free fatty acids. Anal Biochem 98: 341-345, 1979.
49. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, and Kemp BE. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996.
50. Stephens TJ, Chen ZP, Canny BJ, Michell BJ, Kemp BE, and McConell GK. Progressive increase in human skeletal muscle AMPKα2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688-E694, 2002.
51. Thornton C, Snowden MA, and Carling D. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 273: 12443-12450, 1998.
52. Tullson PC, Whitlock DM, and Terjung RL. Adenine nucleotide degradation in slow-twitch red muscle. J Physiol 520: 909-920, 1990.
53. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA, and Ruderman NB. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272: 13255-13261, 1997.
54. Winder WW and Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277: E1-E10, 1999.
55. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutbet CA, Call GB, Clayton RD, Conley LM, Yoon S, and Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82: 219-225, 1997.
56. Witters LA, Gao G, Kemp BE, and Quistorff B. Hepatic 5′-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys 308: 413-419, 1994.
57. Wojtaszewski JFP, Jorgensen SB, Hellsten Y, Hardie DG, and Richter EA. Glycogen dependent effects of AICAR on 5′AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002.
58. Wojtaszewski JFP, Mourtzakis M, Hilling T, Saltin B, and Pilegaard H. Dissociation of AMPK activity and ACCβ phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 298: 309-316, 2002.
59. Wojtaszewski JFP, Nielsen P, Hansen BF, Richter EA, and Kiens B. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528: 221-226, 2000.
60. Woods A, Munday MR, Scott J, Yang X, Carlson M, and Carling D. Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem 269: 19509-19515, 1994.
61. Yeaman SJ, Armstrong JL, Bonavaud SM, Poinasamy D, Pickersgill L, and Halse R. Regulation of glycogen synthesis in human muscle cells. Biochem Soc Trans 29: 537-541, 2001.